CSL Ph I trials of proposed COVID-19 vaccine commence

Jul 13, 2020

CSL announced it has commenced Ph I trials of its proposed COVID-19 vaccine. The clinical batch of vaccine for use in the trial has been manufactured by the UQ and CSIRO, with technical assistance from CSL and Cytiva.

Print Page Mail Article